HKPJ Article - Use of Aprocitentan and Spironolactone in Resistant Hypertension Management (For 2026/27 CPE Cycle)

CPE points : 2 per article (after reading the article and passing the post-reading quiz - Pass mark 60%) A Certificate of Completion will be issued to the participant in due course for claiming the CPE points.

FOR THOSE WHO ATTEMPT THE QUIZ ON OR AFTER 1-06-2026, CPE POINTS WOULD BE AWARDED FOR THE 2026/27 CPE CYCLE)

Download article (Web version) :

https://hkpj.org/en/blog-detail.php?id=110&vol=84

Download article (PDF version)

/ufiles/userfiles/files/Use%20of%20Aprocitentan%20and%20Spironolactone%20in%20Resistant%20Hypertension%20Management(1).pdf

Attempt quiz :

https://docs.google.com/forms/d/e/1FAIpQLSdlvg30A7VGDd7Mb6I9HN9SGtqxvZpxGPrDif2ttUHdmTOp-w/viewform

Submission deadline : 20-Aug-2026

N.B. Self-study limited to 7 CPE points per cycle with reflective report (or certificate of passing a post-quiz)

Date:

2026-06-01 to 2026-08-20

Venue:

Online

Organising Institute:

Hong Kong Pharmaceutical Journal

Related CPE Activities:

Article: Supporting Safe Anticoagulation Use in the Community Setting

Organising Institute:
US Pharm. 2026;51(2):28-32

17-Jul-2026

HKPJ Article - Use of Aprocitentan and Spironolactone in Resistant Hypertension Management (For 2025/26 CPE cycle)

Organising Institute:
Hong Kong Pharmaceutical Journal

1-May-2026
to 31-May-2026

IT Basics for AI

Organising Institute:
European Compliance Academy

8-Feb-2026

HKPJ Article: Probiotics in Healthcare: From Gut Health to Systemic Effects - A Narrative Review

Organising Institute:
Hong Kong Pharmaceutical Journal

20-Jan-2026
to 31-Mar-2026

HKPJ Article: Drugs & Therapeutics Review of Current CAR-T Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Adults: Tisagenlecleucel (Kymriah®) and Axicabtagene Ciloleucel (Yescarta®)

Organising Institute:
Hong Kong Pharmaceutical Journal

15-Sep-2025
to 30-Nov-2025

Downloads

Useful Links